摘要
目的:寻找肺鳞状细胞癌组织中与正常组织中差异表达的微小RNA(miRNA),并对其进行生物学功能的预测及验证。方法:应用芯片技术筛选30例肺鳞癌组织中与正常组织中差异表达的miRNA。选取差异表达的mir-182家族进行定量PCR验证,通过生物信息学网站预测其靶基因,并在体外进行荧光素酶报告基因验证。结果:Hsa-mir-182家族在肺鳞癌组织中表达丰度较正常组织明显升高。生物信息学网站预测发现,RASA1可能是mir-182的靶基因。体外过表达mir-182后,发现RASA1表达量显著下降,验证了RASA1确实为mir-182的靶基因。结论:Hsa-mir-182家族在肺鳞癌组织中显著高表达,而且RASA1基因系mir-182的靶基因。
OBJECTIVE:To detect the different expression of microRNA (miRNA) in lung squamous cell cancer and to predict and validate their biological function. MEI^Ol~:Microarray was used to discover the special miRNA which was differentially ex- pressed between lung squamous cell cancer tissues and normal lung tissues. The mir-182 family which was significantly upregulated in lung squamous cell cancer tissues were tested through qualitative PCR. The target genes were predicted by public algorithms and con- firmed in v/vo. RESULTS: Hsa-mir-182 family was highly expressed in lung squamous cell carcinoma. After mir-182 being overex- pressed,the expression of RASA1 was significantly down regulated, which further confirmed that RASA1 was the target gene of mir-182. CONCLUSIONS:Hsa-rnir-182 family is significantly high expressed in lung squamous cell cancer. Mir-182 downregulates RASA1 and it may play an important role in lung squamous cell cancer.
出处
《中华肿瘤防治杂志》
CAS
北大核心
2013年第16期1225-1228,共4页
Chinese Journal of Cancer Prevention and Treatment